INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Highlights Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
28.34 ^USD	-0.25%		-1.19%	-34.93%

Apr. 04	North American Morning Briefing : Focus Turns to -2-	DJ
Apr. 03	Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Integra LifeSciences Completes Acquisition of Acclarent	Apr. 01	MT
Integra LifeSciences Holdings Corporation acquired 100% stake in Acclarent, Inc. from Ethicon US, LLC for $280 million.	Mar. 31	CI
Integra Lifesciences Launches Micromatrix Flex to Provide Convenient Access to Hard-To-Reach Areas in Complex Cases	Mar. 11	CI
Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on July 27, 2023.	Feb. 28	CI
Integra LifeSciences Shares Drop Following Q4 Results	Feb. 28	MT
Integra LifeSciences Seeks Acquisitions	Feb. 28	CI
Integra LifeSciences' Q4 Adjusted Earnings, Revenue Decline	Feb. 28	MT
Integra Lifesciences Holdings Corporation Provides Earnings Guidance for the First Quarter and for the Full Year 2024	Feb. 28	CI
Integra LifeSciences Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Posts Q4 Revenue $397M, vs. Street Est of $399.2M	Feb. 28	MT
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Reports Q4 EPS $0.89, vs. Street Est of $0.90	Feb. 28	MT
Integra LifeSciences Holdings Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Integra LifeSciences Agrees to Buy Acclarent for $275 million at Deal Closing	Dec. 13	MT
Integra LifeSciences to Buy Acclarent From Johnson & Johnson	Dec. 13	DJ
Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire 100% stake in Acclarent, Inc. from Ethicon US, LLC for $280 million.	Dec. 12	CI
Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on July 27, 2023.	23-10-25	CI
Escalating Middle East Tension, Earnings Weigh on Exchange-Traded Funds, Equity Futures Pre-Bell Wednesday	23-10-25	MT
Integra LifeSciences' Q3 Adjusted Earnings, Revenue Slip	23-10-25	MT
Integra LifeSciences Holdings Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2023	23-10-25	CI
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Posts Q3 Revenue $382.4M, vs. Street Est of $387.1M	23-10-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Highlights

Filters